- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Eliciting neutralizing antibodies with gp120 outer domain ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Creator
-
Qin, Y.
- Contributor
-
Han, DP
Takamoto, K.
Cho, MW
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-O11
- URN
-
urn:nbn:de:1111-2016080727122
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Qin, Y.
- Han, DP
- Takamoto, K.
- Cho, MW
- SpringerLink (Online service)
Other Objects (12)
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Retracted: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Retraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
P05-08. Eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein gp120: A strategy
Synthetic Neoglycoconjugates of Hepta‐ and Nonamannoside Ligands for Eliciting Oligomannose‐Specific HIV‐1‐Neutralizing Antibodies
Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine
NMR spectroscopy of HIV-1 gp120 outer domain
Broadly Neutralizing Antibodies for HIV Eradication
HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120
Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and co-receptor binding sites of HIV-1 gp120
Engineered gp120 immunogens that elicit VRC01-like antibodies by vaccination
Immunogenicity of the outer domain of a HIV-1 clade C gp120
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Retracted: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Retraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
P05-08. Eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein gp120: A strategy
Synthetic Neoglycoconjugates of Hepta‐ and Nonamannoside Ligands for Eliciting Oligomannose‐Specific HIV‐1‐Neutralizing Antibodies
Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine
NMR spectroscopy of HIV-1 gp120 outer domain
Broadly Neutralizing Antibodies for HIV Eradication
HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120
Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and co-receptor binding sites of HIV-1 gp120
Engineered gp120 immunogens that elicit VRC01-like antibodies by vaccination
Immunogenicity of the outer domain of a HIV-1 clade C gp120
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Retracted: Eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
Retraction Note: eliciting broadly neutralizing antibodies against HIV-1 that target gp41 MPER
P05-08. Eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein gp120: A strategy
Synthetic Neoglycoconjugates of Hepta‐ and Nonamannoside Ligands for Eliciting Oligomannose‐Specific HIV‐1‐Neutralizing Antibodies
Eliciting CD4-mimicking broadly neutralizing antibodies: new avenues towards the rational design of an HIV vaccine
NMR spectroscopy of HIV-1 gp120 outer domain
Broadly Neutralizing Antibodies for HIV Eradication
HIV-1 envelope trimer elicits higher neutralizing antibody responses than monomeric gp120
Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and co-receptor binding sites of HIV-1 gp120
Engineered gp120 immunogens that elicit VRC01-like antibodies by vaccination